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Abstract: Selenium is an essential trace element involved in the body’s redox reactions. Low selenium
intake during pregnancy has been associated with low birth weight and an increased risk of children
being born small for gestational age (SGA). Based on data from the Norwegian Mother, Father and
Child Cohort Study (MoBa) and the Medical Birth Registry of Norway (MBRN), we studied the
association of maternal selenium intake from diet and supplements during the first half of pregnancy
(n = 71,728 women) and selenium status in mid-pregnancy (n = 2628 women) with birth weight and
SGA status, according to population-based, ultrasound-based and customized growth standards. An
increase of one standard deviation of maternal dietary selenium intake was associated with increased
birth weight z-scores (ß = 0.027, 95% CI: 0.007, 0.041) and lower SGA risk (OR = 0.91, 95% CI 0.86, 0.97)
after adjusting for confounders. Maternal organic and inorganic selenium intake from supplements
as well as whole blood selenium concentration were not associated with birth weight or SGA. Our
results suggest that a maternal diet rich in selenium during pregnancy may be beneficial for foetal
growth. However, the effect estimates were small and further studies are needed to elucidate the
potential impact of selenium on foetal growth.
Keywords: birth weight; intrauterine growth; selenium; the Norwegian Mother, Father and Child
Cohort study; MoBa; Medical Birth Registry of Norway; MBRN
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1. Introduction
Intrauterine growth retardation (IUGR) and small for gestational age (SGA) are associ-
ated with intrauterine foetal death [1], cerebral palsy [2], perinatal acidosis, hypoglycaemia,
hypothermia, and coagulation abnormalities [3]. Later in life, SGA born children are at
higher risk of short stature, cognitive delays, diabetes and cardiovascular disease [3–6].
Some risk factors for having a baby born SGA, such as maternal smoking, maternal weight
(very low and also increased body mass index) and primiparity, have been identified [7–10].
In addition, a number of dietary factors have been associated with SGA, such as diet
quality/unhealthy dietary patterns [11–13], high sugar consumption in pregnancy [14], low
consumption of seafood [15,16], low iodine intake [17], and caffeine consumption [18,19].
A review on the impact of maternal diet during pregnancy on infant birth weight found
that consumption of whole foods such as fruit, vegetables, low-fat dairy, and lean meats
throughout pregnancy may be beneficial for appropriate birth weight in relation to gesta-
tional age [20]. Studies examining associations between maternal/neonatal trace element
concentrations during pregnancy and SGA status found selenium concentration, but not
iron, zinc, copper, cadmium or lead, to be significantly associated with the risk of being
born SGA [21–23].
Selenium is a trace element which is incorporated into selenoproteins. Examples of
important selenoproteins are the key antioxidative enzyme glutathione peroxidase and
the iodothyronine deiodinases D1, D2, and D3, each containing selenium at their active
sites [24]. Glutathione peroxidase has a major impact on redox status and regulates oxida-
tive stress, while the iodothyronine deiodinases have key roles in regulating circulating
and intracellular levels of thyroid hormones [25]. We have previously reported that mater-
nal dietary selenium intake is associated with a small but significant decrease in the risk
of preterm delivery and an increase in gestational duration [26]. There are also studies
suggesting that maternal blood selenium status before or during pregnancy correlates
positively with birth weight [23,27].
The aim of this study was to examine whether maternal intake of selenium and
maternal whole blood selenium concentration in mid-pregnancy are associated with birth
weight and SGA in a large Norwegian pregnancy cohort.
2. Materials and Methods
2.1. Study Population
The Norwegian Mother, Father and Child Cohort Study (MoBa) is an ongoing, prospec-
tive, population-based pregnancy cohort administered by the Norwegian Institute of Public
Health [28] including women from all of Norway between 1999 and 2008. Pregnant women
were invited by postal invitation in connection with the routine ultrasound screening in
gestational week 18. The women consented to participation in 41% of the pregnancies. The
cohort now includes 114,500 children, 95,200 mothers and 75,200 fathers [28]. Participants
were asked to fill in questionnaires covering a wide range of information at several time
points during pregnancy and childhood. This study is based on information from question-
naire 1 (Q1) about general health status and lifestyle filled in around gestational week 15
to 17 and on the semi-quantitative food frequency questionnaire (FFQ) filled out around
gestational week 22 (Q2). Pregnancy and birth records from the Medical Birth Registry of
Norway (MBRN) were linked to the MoBa dataset [28]. MBRN is a national health registry
containing information about all births in Norway. Blood samples were obtained from both
parents during pregnancy and from mothers and children (umbilical cord) at birth. The
current study is based on version 10 of the quality-assured data files released for research
in 2017. The establishment and initial data collection in MoBa were based on a license from
the Norwegian Data Protection Agency and approval from The Regional Committee for
Medical and Health Research Ethics. The MoBa cohort is now based on regulations related
to the Norwegian Health Registry Act. The current study was approved by The Regional
Committee for Medical Research (2015/2425/Rek South-East A).
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Only women with singleton live births after gestational week 22+0 and women with
valid information on selenium intake (i.e., total energy intake between 4.5 and < 20 MJ/day
and less than 3 blank pages in the FFQ) were included. Women who participated in the
cohort with more than one pregnancy were included in the present study only with their
first enrolled pregnancy (see Figure 1 for selection of the study population). Subjects with >
4 standard deviations from the mean in the birth weight or selenium intake variables were
excluded, resulting in 71,728 individuals included in the statistical analyses for selenium
intake and 2628 for analysis of selenium status (Figure 1).
Figure 1. Flow chart over the study population. * The current food frequency questionnaire (FFQ) was not used before 2002,
explaining the large drop of numbers from box 2 to 3.
2.2. Maternal Intake of Selenium
Maternal daily intake (µg/day) of selenium from food and dietary supplements was
estimated based on self-reported intake using the semi-quantitative MoBa food frequency
questionnaire (FFQ) designed to assess habitual diet and intake of dietary supplements
during the first four to five months of pregnancy [29]. The FFQ included questions about
the intake of 255 food items or dishes and the FFQ was used from March 2002 throughout
the remaining recruitment period. The questionnaire was optically read, and the consump-
tion frequencies were converted into food amounts (gram/day) using standard Norwegian
portion sizes. FoodCalc [30] and the Norwegian food composition table were used for
calculating the intakes of selenium and other nutrients from food. As previously de-
scribed [26], the participants reported the use of dietary supplements by writing the name
and brand of the supplement as well as the frequency and amount. Selenium intake from
supplements was calculated from a database of more than 1000 dietary supplements [31].
The content of selenium in the different supplements was based on the producers’ declared
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nutrient content information. The selenium supplements contained one or more forms of
selenium, including inorganic selenite or selenate and organic forms of selenium such as
selenomethionine and selenised yeast. The supplementary intake of selenium was analysed
separately for organic and inorganic supplements, since these forms differ in impact on
tissue selenium concentration.
The FFQ used in MoBa has been thoroughly validated in 119 MoBa participants using
a four-day weighed food diary and biological markers in blood and urine as reference
measures [32,33]. The validation study showed that the MoBa FFQ is a valid tool for
assessing dietary intake of energy, nutrients and food in the first four to five months of
pregnancy.
2.3. Selenium Concentration in Whole Blood
Data on selenium concentration in whole blood were available for a sub-sample of 2638
women included in the Norwegian Environmental Biobank [34,35]. Whole blood collected
in heparin tubes in gestational weeks 17–18 was shipped by ordinary mail (unrefrigerated
shipment) in a vacutainer for long-term storage at −20 ◦C at a central biorepository [35,36].
Selenium was analysed at Lund University, Sweden, by inductive couple plasma mass
spectrometry (ICP-MS; iCAP Q, Thermo Fisher Scientific, Bremen, Germany, GmbH)
equipped with a collision cell with kinetic energy discrimination and helium as collision
gas. The detection limit was 3.2 µg/L and the coefficient of variation was 1.5%. All
samples were above the detection limit. The analytical accuracy was verified against
certified reference material, Seronorm Trace elements whole blood L-1 and L-2 (SERO AS,
Billingstad, Norway).
2.4. Birth Weight and SGA
Birth weight was recorded in the MBRN [37]. In addition to birthweight in grams,
birth weight was examined as continuous (z-scores) and dichotomous (small for gestational
age, SGA) outcome variables based on the following growth standards:
(a) Population-based SGA:<10th percentile according to MBRN birth weight z-score
based on infants’ weight gestational age sex from all deliveries included in MBRN
from 1967 to present. Calculated by MBRN based on Skjærven’s gestational age-based
growth curves [38].
(b) Ultrasound-based SGA: >2 standard deviations (SD) below the expected birth weight
(z-score) for any given gestational age according to Marsal’s ultrasound-derived
growth curves [39].
(c) Customized SGA: <10th percentile of birth weight z-score according to Gardosi et al. [40]
based on Hadlock et al.’s ultrasound-derived growth curves [41], and taking infant
sex, maternal weight, height, and parity into account [42].
The population-based definition of SGA (a) is used as the main outcome and these
results are presented in the main text, while the results from the ultrasound-based (b) and
the customized-based (c) SGA analyses are presented in the Supplementary Material).
2.5. Covariates
Multivariate analyses were performed with and without adjustment for the following
potential confounders: maternal age at delivery, maternal pre-pregnancy body mass index
(BMI), parity, maternal smoking habits during pregnancy, passive smoking, and maternal
education. Models for selenium intake (from diet or from inorganic or organic supplements)
were also adjusted for nausea during second trimester, fibre intake, iodine intake, protein
intake, n-3 intake from diet and total energy intake, as well as mutually adjusted for the
different selenium sources (diet intake, organic supplements and inorganic supplements).
Fish intake has previously been found to be positively associated with higher birth
weight in MoBa [43]. To account for confounding from other compounds in fish, all models
were adjusted for marine omega-3 polyunsaturated fatty acids from food. Other important
sources of selenium in the diet are meat and dairy products. Protein intake from dairy
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products has been found to be associated with birth weight and SGA [44]. To account for
confounding by meat and dairy products, total protein intake was included in all adjusted
models. Iodine was included in the model for dietary selenium since selenium and iodine
share some of the same food sources and iodine has been found to be associated with
foetal growth in MoBa [17]. In addition, we adjusted for total energy intake to account for
an overall higher intake among women with high selenium intake and for fibre intake to
account for an overall healthy eating behaviour.
Data on maternal age at delivery were available from MBRN and used as a contin-
uous variable. Maternal pre-pregnancy BMI was based on self-reported pre-pregnancy
height and weight and grouped according to the WHO classification as underweight
(<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and obese
(≥30.0 kg/m2). Information on parity was based on data from both MBRN and MoBa
questionnaires and divided into three categories: 0, 1 or >1 previous birth. Maternal educa-
tion was categorized as <13, 13–16, >16 years. Smoking during pregnancy was categorized
as non-smoking, occasional, or daily smoking reported in Q1. Alcohol intake calculated
from the FFQ was converted to a binary variable (yes or no). Iodine intake was ranked into
quintiles. Dietary fibre, total protein intake and total energy intake in kilo Joules (kJ) were
added as continuous variables.
2.6. Statistical Methods
All statistical analyses were performed using IBM SPSS Statistics version 27.0 and
R version 3.5.0. All p-values were two-sided, and the thresholds for significance were
corrected for the total number of regression models in the main analyses (0.05 / (4 exposure
× 3 outcomes) ≈ 0.004). Differences in selenium intake and selenium status according
to maternal characteristics were studied with the Kruskal–Wallis test. Prior to analysis,
selenium intake was standardized, and selenium blood concentration was log transformed.
Linear regression was used to analyse the association between standardized selenium
intake or log transformed whole blood selenium concentration and birth weight as a
continuous variable. The association between standardized selenium intake (from diet,
or from supplements—organic or inorganic) or log transformed whole blood selenium
concentration and SGA was analysed with logistic regression. All analyses were performed
with and without adjustment for the predefined potential confounders described above.
3. Results
3.1. Selenium Intake and Status in the Study Population
In the full study sample, the median (25th–75th percentile) total intake of selenium from
diet and selenium-containing supplements was 61 (48–86) µg/day. Selenium intake from diet
was 53 (44–62) µg/day, and 29% had selenium intake from food above the recommended
daily intake (RDI) of 60 µg/day [45]. In selenium supplement users (n = 23,336, 32.5% of the
total population), selenium intake from supplements was 50 (30–75) µg/day and from diet
was 53 (44–62) µg/day in this group. A total of 20,745 women took supplements containing
inorganic supplements, 3,277 women took supplements containing organic selenium and
686 women took both inorganic and organic selenium supplements. Selenium supplement
users had a slightly higher intake of selenium from diet than non-users and slightly higher
blood selenium concentration (Table 1). The median (25th–75th percentile) concentration
of blood selenium in the subgroup of 2572 women was 102 (89–117) µg/L, and 54% had a
concentration above the reference value for adequate selenium status of 100 µg/L for whole
blood [46]. The distribution of selenium intake from diet is shown in Figure 2. The most
important contributors to selenium intake were cereals and grains, seafood, meat and egg,
milk and dairy products. In Norway, no food items are fortified with selenium.
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Table 1. Selenium intake and selenium status by maternal characteristics.
Selenium from Diet µg/day Selenium in Whole Blood µg/L
n Median 25th–75th Percentile n Median 25th–75th Percentile
Total population 71,728 53 44–62 2,628 102 89–117
Maternal age, years
<25 8239 50 41–61 220 98 86–112
25–29 24,313 52 43–62 945 102 88–116
30–34 26,884 53 45–63 1173 102 90–118
>34 12,292 54 46–64 290 104 92–120
Pre-pregnancy BMI,
kg/m2
<18.5 2130 53 44–64 81 104 91–119
18.5–24.9 45,976 53 45–63 1699 103 90–119
25–29.9 15,134 52 43–61 608 101 88–115
>30 6633 51 42–61 193 100 86–114
Missing 1855 52 44–62 47 100 93–111
Parity
0 38,169 52 43–62 1511 104 91–119
1 21,557 53 44–62 751 101 88–115
2+ 11,945 54 45–63 365 99 87–114
Missing 57 56 45–63 1 112 112–112
Maternal education,
years
<13 22,286 51 42–62 674 100 86–114
13–16 29,757 53 44–62 1244 101 88–116
>16 18,150 54 46–64 653 107 94–122
Missing 1535 51 42–62 57 99 87–115
Maternal smoking
during pregnancy
Never 65,504 53 44–62 2452 102 90–118
Occasionally 1943 52 43–63 63 99 91–113
Daily 3876 51 42–62 103 95 85–110
Missing 405 52 43–62 10 97 93–108
Passive smoking
No 62,767 53 44–62 2364 102 89–117
Yes 7580 52 43–63 224 100 87–114
Missing 1381 51 43–63 40 101 86–119
Nausea during
second trimester
No 63,504 53 44–62 2341 102 90–118
Yes 8224 52 42–62 287 97 87–114
Gestational age,
weeks
<33 942 51 43–61 7 90 83–96
34–36 2654 53 44–62 72 104 93–114
37–38 11,612 53 44–62 408 102 89–117
>38 56,520 53 44–62 2141 102 89–117
Iodine intake,
µg/day
<89 17,942 43 36–50 641 101 88–118
89–121 17,942 50 43–58 676 104 89–118
121–162 17,934 55 48–63 685 102 90–118




≤0.24 23,934 45 44–68 866 98 87–112
0.24–0.43 23,911 52 45–61 963 104 90–118
≥0.43 23,804 61 52–71 799 106 92–120
Fibre intake, g/day
<26 23,951 43 37–51 867 101 88–116
26–34 23,941 53 46–60 931 102 89–117
>34 23,836 63 55–72 830 104 90–118
Protein intake,
g/day
<76 23,952 42 36–48 864 102 88–117
76–93 23,950 53 47–59 905 102 90–117
>93 23,826 65 58–74 859 102 90–117
Energy intake,
MJ/day
<8389 23,950 44 37–50 909 103 90–118
8392–10,460 23,946 53 46–60 892 102 89–117
>10,460 23,832 63 55–73 827 101 89–116
Selenium
supplement intake
Yes 23,336 53 44–63 814 100 88–115
No 48,392 52 44–62 1814 106 94–121
Amount of daily selenium intake from food (FFQ data) and concentration of blood selenium in mid pregnancy according to maternal
characteristics, from 71,728 participants in the Norwegian Mother and Child Cohort Study. Selenium intake from food was assessed with a
food frequency questionnaire in gestational week 22. Blood selenium concentration was measured in whole blood collected in gestational
week 17–18 in a subsample of 2628. Abbreviations: BMI—Body Mass Index; MJ—Mega Joule; PUFA—polyunsaturated fatty acids.
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Figure 2. Sources of selenium from food, percent mean contribution to the total dietary selenium intake.
3.2. Maternal Characteristics and Selenium Intake
Table 1 describes the maternal characteristics of all 71,728 women by selenium intake
and selenium status. Higher dietary intake was associated with higher age and educa-
tion, lower BMI, no maternal smoking or passive smoking and no nausea during second
trimester. Higher maternal dietary selenium intake was also associated with higher mater-
nal intake of iodine, long chain n-3 polyunsaturated fatty acids, fibre, protein and energy
(Table 1).
3.3. Birth Weight
The mean birth weight was 3582 g (standard deviation (SD): 560 g). In total, 4952
(6.9%) infants were born SGA according to the population-based growth curve. Based on
ultrasound-based and customized growth curves, 1422 (2.0%) and 10,237 (14.5%) infants,
respectively, were classified as SGA.
3.4. Maternal Dietary Selenium Intake and Birth Weight and SGA
Maternal dietary selenium intake during the first four to five months of pregnancy
was significantly associated with higher birth weight and population-based birth weight
z-scores adjusted ß = 0.027 (95% CI: 0.007, 0.014) per SD, i.e., 14.3 µg/day of selenium intake
(Table 2). Likewise, significant positive associations were found for maternal selenium
intake and birth weight percentiles according to ultrasound-based and customized growth
standards, adjusted ß (95% CI) = 0.7 (0.3, 1.1) per SD of selenium intake for both definitions
(Supplementary Table S1).
We tested for interactions between selenium intake from food and blood selenium
as well as interactions between selenium intake from supplements and blood selenium
on population-based z-scores of birth weight adjusted for gestational duration and sex.
No interactions were found (p-value > 0.72), so we only present the effect estimates for
selenium intake and blood selenium without the interaction.
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Table 2. Associations between maternal dietary selenium intake and birth weight in 71,728 women from the Norwegian
Mother, Father and Child Cohort study.
Birth Weight, Grams Z-Scores
n ß2 (95% CI) SE P ß2 (95% CI) SE P
Unadjusted 71,728 18 (14, 22) 2.1 2.2 × 10−17 0.032 (0.025, 0.039) 0.004 6.2 × 10−19
Adjusted 1 66,923 12 (6, 18) 3.1 1.0 × 10−4 0.027 (0.013, 0.040) 0.007 1.0 × 10−4
Multiple linear regression analysis of standardized selenium intake from food in relation to birth weight in grams and z-scores of birth
weight according to gestational age. Birth weight z-scores were calculated according to population-based growth curves. 1 Adjusted for
maternal age at delivery, maternal pre-pregnancy body mass index (BMI), parity, maternal smoking during pregnancy, passive smoking,
nausea during second trimester, maternal education, fibre intake, iodine intake, protein intake, n-3 intake from diet, selenium intake from
supplements and total energy intake. 2 ß per SD of selenium intake in µg/day, i.e., 14.3 µg/day. Unadjusted models included 71,728
women while the adjusted models included 66,923 women due to missing data on the covariates. Abbreviations: ß—beta, CI—confidence
interval, SE—standard error.
Higher maternal dietary selenium intake was significantly associated with a lower
risk of SGA according to the population-based z-score definition (adjusted OR = 0.91,
95% CI 0.86, 0.97, per SD of selenium intake) (Table 3). The results were comparable for the
customized defined SGA, but not significant for the ultrasound-based SGA which included
fewer SGA cases, OR (95% CI) 0.95 (0.91, 0.99) and 0.93 (0.84, 1.04) per SD of selenium
intake, respectively (Supplementary Table S2).
Table 3. Associations between maternal dietary selenium intake and small for gestational age (SGA)
birth in 71,728 women from the Norwegian Mother, Father and Child Cohort study.
SGA
n total n SGA OR 2 (95% CI) p
Unadjusted 71,728 4952 0.92 (0.90, 0.95) 8.24 × 10−8
Adjusted 1 66,923 4614 0.92 (0.86, 0.97) 0.003
Multiple logistic regression of standardized maternal dietary selenium intake in relation to small for gestational
age according to population-based growth curve. 1 Adjusted for maternal age at delivery, maternal pre-pregnancy
body mass index (BMI), parity, maternal smoking during pregnancy, passive smoking, nausea during second
trimester, maternal education, fibre intake, iodine intake, protein intake, n-3 intake from diet, selenium intake from
supplements and total energy intake. 2 OR per SD of selenium intake in µg/day, i.e., 14.3 µg/day. Unadjusted
models included 71,728 women while the adjusted model included 66,923 women due to missing data on the
covariates. Abbreviations: CI—confidence interval, OR—odds ratio, SGA—small for gestational age.
3.5. Maternal Selenium Intake from Supplements and Birth Weight and SGA
The association between maternal selenium intake from supplements and birth weight
was explored for organic and inorganic selenium separately (Table 4). We found no
association between maternal organic supplement intake and birth weight (adjusted ß:
−1.20 per SD, i.e., 10.4 µg/day, 95% CI: −4.40, 2.00). However, the association between
maternal inorganic supplement intake and birth weight was nominally significant (adjusted
ß: 4.30 per SD, i.e., 33.0 µg/day, 95% CI: 1.06, 7.53), but did not reach significance after
Bonferroni correction for multiple comparisons. We observed similar results for both
organic and inorganic selenium supplement intake when using birth weight percentiles
according to ultrasound-based and customized growth standards (Supplementary Table
S3). After Bonferroni correction, only the association between inorganic selenium intake
and customized birth weight standards was significant in the adjusted model (ß: 0.83 per
SD, 95% CI: 0.34, 1.32, Supplementary Table S3).
Maternal selenium intake from supplements was not associated with SGA (Table 5),
adjusted OR: 1.00 per SD (95% CI: 0.97, 1.03) and OR: 1.00 per SD (95% CI: 0.97, 1.03), re-
spectively, for organic and inorganic selenium intake from supplements. Analyses using the
customized-based and ultrasound-based definitions supported these null findings (Supple-
mentary Table S4).
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Table 4. Associations between maternal selenium intake from supplements and birth weight in 71,728 women from the
Norwegian Mother, Father and Child Cohort study.
Birth Weight, Grams Z-Scores
n ß2 (95% CI) SE p ß2 (95% CI) SE p
Organic
selenium
Unadj 71,698 −0.79 (−4.89, 3.30) 2.09 0.705 −0.01 (−0.01, 0.00) 0.00 0.140
Adj 1 65,772 −1.20 (−4.40, 2.00) 1.63 0.462 0.00 (−0.01, 0.00) 0.00 0.512
Inorganic
selenium
Unadj 71,698 −5.08 (−9.18, −0.98) 2.09 0.015 −0.01 (−0.01, 0.00) 0.00 0.033
Adj 1 65,772 4.30 (1.06, 7.53) 4.30 0.009 0.02 (0.01, 0.00) 0.01 0.024
Multiple linear regression analysis of standardized selenium intake from supplements in relation to birth weight in grams and z-scores of
birth weight according to gestational age. Birth weight z-scores were calculated according to population-based growth curves. 1 Adjusted
for food selenium intake, maternal age at delivery, maternal pre-pregnancy body mass index (BMI), parity, maternal smoking during
pregnancy, passive smoking, nausea during second trimester, maternal education, fibre intake, iodine intake, protein intake, n-3 intake
from diet, selenium intake from supplements (inorganic and organic for its respective model) and total energy intake.2 ß per SD of
selenium intake from supplements in µg/day. SD for organic selenium: 10.4 µg/day and for inorganic selenium: 33.0 µg/day. Unadjusted
models included 71,698 women while the adjusted models included 65,772 women due to missing data on the covariates. Abbreviations:
Adj—adjusted, ß—beta, CI—confidence interval, SE—standard error, Unadj—unadjusted.
Table 5. Associations between maternal selenium intake from supplements and small for gestational age status in
71,728 women from the Norwegian Mother, Father and Child Cohort study.
SGA
n Total n SGA OR 2 (95% CI) p
Organic selenium Unadjusted 71,723 4952 1.01 (0.98, 1.03) 0.601
Adjusted 1 66,923 4614 1.00 (0.97, 1.03) 0.980
Inorganic selenium Unadjusted 71,723 4952 1.02 (0.99, 1.04) 0.256
Adjusted 1 66,923 4614 0.99 (0.96, 1.02) 0.588
Multiple logistic regression of standardized maternal intake of selenium from supplements in relation to small for gestational age according
to population-based growth curve. 1 Adjusted for dietary selenium intake, maternal age at delivery, maternal pre-pregnancy body mass
index (BMI), parity, maternal smoking during pregnancy, passive smoking, nausea during second trimester, maternal education, fibre
intake, iodine intake, protein intake, n-3 intake from diet, selenium intake from supplements (inorganic and organic for its respective
model) and total energy intake. 2 OR per SD of selenium intake from supplements in µg/day. SD for organic selenium: 10.4 µg/day and
for inorganic selenium: 33.0 µg/day. Unadjusted models included 71,723 women while the adjusted model included 66,923 women due to
missing data on the covariates. Abbreviations: CI—confidence interval, OR—odds ratio, SGA—small for gestational age.
3.6. Maternal Whole Blood Selenium Concentration, Birth Weight and Small for Gestational Age
Maternal whole blood selenium concentration was not associated with birth weight
or birth weight z-scores (Table 6). Similarly, associations between whole blood selenium
concentration and birth weight percentiles according to ultrasound-based and customized
z-scores were non-significant (Supplementary Table S5).
Maternal whole blood selenium concentration was not associated with SGA (Table 7).
Similarly, the associations between maternal whole blood selenium concentration and SGA
according to the other two growth curves were also non-significant (Supplementary Table S6).
Table 6. Associations between maternal selenium concentration in whole blood and birth weight in 2628 women from the
Norwegian Mother, Father and Child Cohort study.
Birth Weight, Grams Z-Scores
n ß2 (95% CI) SE p ß2 (95% CI) SE p
Unadjusted 2628 −0.97 (−1.89, −0.05) 46.8 0.038 −0.003 (−0.004, −0.001) 0.09 0.005
Adjusted 1 2488 −0.47 (−1.29, 0.34) 41.6 0.254 −0.001 (−0.003, 0.001) 0.09 0.195
Multiple linear regression analysis of log transformed maternal selenium concentration in whole blood collected during pregnancy in
relation to birth weight in grams, z-scores of birth weight according to gestational age. Birth weight z-scores were calculated according to
population-based growth curve. 1 Adjusted for maternal age at delivery, maternal pre-pregnancy body mass index (BMI), parity, maternal
smoking during pregnancy, passive smoking and maternal education. 2 ß per % of blood selenium. Crude models included 2628 women
while adjusted models included 2488 women due to missing data on the covariates. Abbreviations: ß—beta, CI—confidence interval,
SE—standard error.
Nutrients 2021, 13, 23 10 of 16
Table 7. Associations between maternal selenium concentration in whole blood and small for gestational age status in 2628
women from the Norwegian Mother, Father and Child Cohort study.
SGA
n Total n SGA OR2 (95% CI) p
Unadjusted 2628 146 1.70 (0.77, 3.70) 0.185
Adjusted1 2488 136 1.24 (0.53, 2.88) 0.623
Multiple logistic regression of log transformed maternal selenium concentration in whole blood collected during pregnancy in relation to
small for gestational age according to population-based growth curves. 1 Adjusted for maternal age at delivery, maternal pre-pregnancy
body mass index (BMI), parity, maternal smoking during pregnancy, passive smoking and maternal education. 2 OR per % of blood
selenium. Crude models included 2628 women while adjusted models included 2488 women due to missing data on the covariates.
Abbreviations: CI—confidence interval, OR—odds ratio, SGA—small for gestational age.
4. Discussion
In this study including 71,728 pregnant women, maternal dietary intake of selenium
during the first half of pregnancy was weakly associated with increased birth weight (12 g
per SD of selenium intake in the adjusted models) and with decreased risk of the child
being born SGA (9% decrease per SD of selenium intake). However, maternal selenium
intake from supplements in 71,728 mothers and whole blood selenium in 2628 mothers
were not associated with birth weight or with SGA.
Foetal growth is dependent on nutrients transported from the maternal to the foetal
circulation across the placenta. The transport of small membrane permeable molecules
such as oxygen and carbon dioxide is influenced mainly by umbilical blood flow and
placental structure, while larger molecules such as amino acids, fatty acids and glucose are
dependent on nutrient transport proteins [47]. The nutrient transport capacity of the pla-
centa is influenced by numerous factors, including hormones, nutrient levels and placental
function [48]. Furthermore, oxidative stress in the placenta has been shown to influence
the transport of nutrients through altering the gene expression of different nutrient trans-
porters (e.g., glucose and amino acid) [49,50]. In vitro studies have shown that selenium
supplementation protects placental cells from oxidative stress through increased expression
of selenium-containing antioxidants, such as glutathione and thioredoxin reductase [51].
Hence, one of the leading hypotheses regarding how selenium may affect foetal growth is
through the selenium-dependent antioxidative defence system [49–52].
Other selenium-dependent proteins are the iodothyronine deiodinase (DIOs) that
are involved in thyroid hormones metabolism [53]. Thyroid hormones are essential in
regulating placental nutrient transport, for example, hyperthyroidism is known to reduce
circulating glucose in foetal tissues [54]. Hence, another hypothesis on how selenium may
influence foetal growth is through regulating the levels of thyroid hormones. In line with
this, mice fed a diet low in selenium had increased levels of both maternal and foetal plasma
levels of the thyroid hormones triiodothyronine (T3) and tetraiodothyronine (T4) [49]. In
humans, studies have found lipid peroxidation and oxidative stress to be associated with
children being born SGA [55,56]. In one of the studies, SGA born children had lower levels
of reduced glutathione (indicating deficient antioxidant defence mechanisms) but higher
concentration of the lipid peroxidation malondialdehyde [56].
Previous observational studies analysing the association between selenium status and
birth weight or SGA births have mainly focused on selenium concentration in maternal
serum, plasma or blood samples, collected either before or during pregnancy [22,23,27] or
at delivery [57–61]. To the best of our knowledge, no study has investigated the association
between maternal dietary intake of selenium and birth weight. Previous studies have
suggested that maternal selenium status during pregnancy, but not at delivery, correlates
positively with birth weight. A nested case-control study within the US Camden Study,
with preterm delivery as the main outcome, found selenium status at around 16 weeks of
gestation to be positively associated with birth weight in infants born at term (n = 126),
but not in infants born preterm (n = 107) [27]. Another study performed in Japan on 44
newborn infants, including maternal serum samples collected around entry to antenatal
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care, found maternal selenium status during pregnancy to be positively associated with
higher birth weight [23]. A UK study on 126 adolescent pregnancies found selenium
concentration in plasma collected at around 30 weeks of gestation to be associated with
higher birth weight scores and with a lower risk of SGA [22]. These suggested positive
associations between maternal selenium status and birth weight were not supported in
the sub-sample in the current study, where selenium status was not associated with birth
weight or SGA. We had information about selenium status in a fairly small subgroup of
the women (3.7%). Still, the current study is far larger than previous studies. One obvious
difference between our study and the previous studies is that we used selenium analysed
in whole blood, while the three other studies used selenium analysed in serum or plasma.
Whole blood selenium concentration reflects both status and uptake while plasma/serum
selenium only reflects short-term status [46]. Hence, the difference in specimen used for
selenium analyses may be one explanation for the different results between the current and
previous studies. In the current study, median selenium status was close to the reference
level of 100 µg/L [46,62].
Possible reasons for why only selenium intake from diet but not from supplements
was associated with birth weight and SGA in this study can only be speculated on. One
reason may be that the women in this cohort have intake levels from diet close to the level
associated with optimal selenoprotein expression and adding further selenium intake from
supplements does not give further improvement in selenoprotein expression. Another
reason might be related to the difficulty in accurately measuring the intake of nutrients
contributed from dietary supplements. Dietary intakes are often more stable over time
while intake from supplements may vary more, especially during pregnancy when many
women care more about their nutritional intake [63,64]. One additional explanation is
that dietary selenium intake may serve as a proxy for a high quality diet containing other
factors that have a beneficial effect on birth weight. As we state in the introduction, for
example, high sugar consumption [14], low fish intake [15,16], low iodine intake [17],
and high caffeine consumption [18,19] have previously been associated with the risk of
being born SGA. However, we adjusted our models for fibre intake as a proxy for an
overall healthy diet, iodine intake, protein intake and n-3 intake from diet. After adjusting
for these and other factors, the effect size was somewhat reduced for selenium intake
association with birth weight but not for SGA. Hence, even if we cannot rule out that
dietary intake of selenium is a proxy for another dietary factor that correlates with the
intake of selenium, we believe that the size of our study, allowing us to adjust for very
many factors including markers for overall food quality, strengthens the validity of our
results. A possible explanation for the lack of association between blood selenium and
birth weight may be that the sub-population with available blood selenium was rather
homogenous and had fairly good selenium status.
The main strength of this study is its large sample size. The study is by far the largest
examining selenium intake from both diet and supplements and whole blood selenium
concentration in relation to birth weight and SGA. Another strength of the current study is
its prospective design with selenium intake assessment during the first half of pregnancy
and with maternal blood collected in mid-pregnancy, since previous studies suggest that
maternal selenium status during pregnancy, but not at delivery, is associated with birth
weight [22,23,27,57–61].
Another strength is the population-based study design, including women from all
over Norway representing women living in different areas and regions, from different
socioeconomic groups and women with diverse dietary habits. Another strength is the
extensive data from questionnaires and the linkage to MBRN allowing us to control for
important covariates.
Still, our study is limited by the observational design and the inherent risk of residual
confounding. There is also a potential influence of self-selection bias as for all cohort
studies. The participation rate in MoBa was 41%; women participating in MoBa are
Nutrients 2021, 13, 23 12 of 16
generally healthier and better educated than the general population of pregnant Norwegian
women [28].
In the main analyses, we used the birth weight z-score variable that was extracted
directly from MBRN. To make the results more comparable to those from other parts of the
world, we analysed z-scores of birth weight and SGA according to different growth stan-
dards. The findings for the association between maternal dietary selenium intake during
pregnancy and higher birth weight and lower risk for SGA were consistent and of similar
size when using the different growth standards as shown in the(Supplementary Files).
The subgroup of women with data on selenium concentration in whole blood was
included in the Norwegian Environmental Biobank Study, where two of the inclusion
criteria for participation was to have answered the first six MoBa questionnaires and to
have provided biological samples. Hence, this subgroup with selenium measurements
does not represent the whole MoBa population, but a highly selected group. The women in
this subgroup included a higher proportion of non-smokers and highly educated compared
with those in the whole MoBa [34]. Thus, a limitation with the current study is that the
generalizability of the selenium blood status may be compromised due to selection bias. In
addition, while we did not identify any association between whole blood selenium and
birth weight or SGA, we cannot rule out that smaller effect estimates might be detected if a
larger and more varied study population with broader variation in selenium concentration
was available.
The dietary intake of selenium was estimated during pregnancy using an FFQ specifi-
cally developed and validated for use in the MoBa cohort [29,31]. All dietary assessment
methods have errors. The use of an FFQ to assess diet has limitations since it is imprecise
and prone to misreporting. Since the selenium content varies according to the selenium
concentration of the soil where crops are grown or the animals graze, it is especially difficult
to assess selenium intake from food composition databases. This difficulty is reflected in
the low correlation between selenium intake from diet and selenium concentration in blood
reported previously (Spearman rho: 0.135 95% CI: 0.10, 0.17) [26]. However, blood selenium
concentration is influenced by homeostatic regulation and by individual differences in
absorption, metabolism and body composition. In the validation study, selenium intake
estimated with the FFQ was significantly correlated with selenium intake estimated using
a 4-day food diary, but the correlation coefficient was low (Spearman’s rho 0.33 (95%CI:
0.16, 0.48)) [32].
5. Conclusions
A maternal diet rich in selenium during pregnancy may be beneficial for infant birth
weight and for reducing the risk of SGA births. These results were not supported by
findings for selenium intake from supplements. Around half of the women had selenium
intake levels below the recommended 60 µg/day and around half had selenium status
below the reference value of 100 µg/L. Hence, the association seen between selenium
intake and birth weight and SGA may not be generalisable to populations with other
levels of selenium intake and status. In addition, due to the observational design of
this study, residual confounding may exist. Further experimental studies are needed to
establish causality.
Supplementary Materials: The following are available online at https://www.mdpi.com/2072-664
3/13/1/23/s1, Table S1: Associations between maternal dietary selenium intake and infant birth
weight percentile according to ultrasound-based and customized growth standards in women in the
Norwegian Mother, Father and Child Cohort study. Table S2. Associations between maternal dietary
selenium intake and infant small for gestational age (SGA) status according to ultrasound-based and
customized growth standards in women from the Norwegian Mother, Father and Child Cohort study.
Table S3. Associations between maternal selenium intake from supplements and infant birth weight
percentile according to ultrasound-based and customized growth standards. Table S4. Associations
between maternal selenium intake from supplements and small for gestational age according to
ultrasound-based and customized growth standards. Table S5. Associations between maternal
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whole blood selenium concentrations and birth weight percentile according to ultrasound-based
and customized growth standards in women from the Norwegian Mother, Father and Child Cohort
study. Table S6. Associations between maternal selenium concentrations in whole blood and infant
small for gestational age (SGA) status according to ultrasound-based and customized definitions in
2628 women in the Norwegian Mother, Father and Child Cohort study
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